The supply of GLP-1 drugs has been increasing, but they’re still expensive for most patients. Here are answers to some ...

The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

In the United States, prescriptions for weight-loss drugs for teens have increased 600 per cent, according to one study. But ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

Despite the price drops, the drugs remain costly. Novo Nordisk cut the price of Wegovy by 23 percent for cash payments from ...

HHS Secretary RFK Jr. removes the COVID-19 vaccine recommendation for healthy kids and pregnant women—the latest in a string of changes to vaccine policies; judge issues an order to halt HHS’ ...

A report published in November by KFF, a health information nonprofit that includes KFF Health News, found only 13 states ...

Biopharma Industry Landscape Report—uncover key trends in obesity, oncology, immunology, and AI, plus top stock picks and ...

Prescription drug market expands rapidly due to AI in pharma, rising diseases, and global access to advanced therapies. The prescription drugs market will grow from $1,240.33B in 2024 to $2,151.63B by ...

A recent survey of six medical specialties in 15 U.S. metropolitan areas finds that the average wait time for physician appointments has increased significantly in recent years. Specialties most ...

Medicare no longer covers Wegovy specifically for weight loss purposes, though coverage may still be available when ...

Are you weening yourself off a compounded version of the drug? Considering switching insurers in order to keep your ...